Research Fellow, Centre for Cancer Research and Cell Biology

Northern Ireland
£33,797 to £40,322
11 Dec 2019
End of advertisement period
06 Jan 2020
Contract Type
Maternity Cover, Permanent
Full Time

Application closing date 06/01/2020  
Salary £33,797 to £40,322  
Job category/type Research

Job description

In this role, you will co-ordinate and project manage ongoing prostate cancer research projects and contribute to the supervision/mentoring of PhD and undergraduate students. The major part of the role will be to undertake and progress research projects in the area of prostate cancer epidemiology. These will include analyses within the Northern Ireland Cancer Registry to assess the role of prescription medication use in prostate cancer outcomes, analyses of existing molecular epidemiology datasets in collaboration with local and international colleagues, and preparation of applications to use publicly available data and subsequent analyses of these data. You will also be involved in supporting the PhD and undergraduate student in dataset preparation and cleaning, and statistical analysis.

This is a maternity position available until 24 November 2020.

The successful candidate must have: 

* Have or be about to about a relevant PhD in epidemiology, statistics, bioinformatics or related field.

* 3 years' relevant experience to include: 

  1. Experience working in prostate cancer research. 
  2. Experience in handling datasets, particularly those including both      clinical/epidemiological and molecular data.
  3. Programming experience using SAS, R, and/or STATA.

The Centre for Cancer Research and Cell Biology (CCRCB) is the beating heart of a comprehensive cancer research programme in Belfast, focused on accelerating the delivery of scientific discovery to clinical application.  CCRCB is the research hub of the Belfast ECMC and the Belfast Experimental Cancer Medicine Centre (ECMC), operating in partnership with the Belfast Health and Social Care Trust. Our integrated clinical and scientific programmes address clinically unmet needs.  Our principal objective is to promote evidence-based, innovative clinical trials in order to underpin improved patient outcomes in high incidence solid tumours of Gastro-Intestinal, Prostatic, Breast and Ovarian origin, and in specific Blood Cancers.  Our unifying research theme is to develop translational outputs, in the form of biomarkers and/or novel therapeutic strategies that enable our Centre to be at the forefront of personalised cancer medicine in these prevalent diseases.

Queen's University Belfast is a driver of innovation based on our talented, multinational workforce. Throughout the University, our academics are collaborating across disciplines to develop new discoveries and insights, working with outside agencies and institutions on projects of international significance. We are connected and networked with strategic partnerships across the world, helping us to expand our impact on wider society locally, nationally and globally. The University is committed to attracting, retaining and developing the best global talent within an environment that enables them to realise their full potential.

We are a leader in gender equality and diversity, and are one of the UK's most successful universities in the Athena SWAN initiative, which promotes gender equality and career progression. The School of Medicine, Dentistry and Biomedical Sciences works to actively drive and implement gender equality and are fully committed to the aims of the Athena SWAN Charter.  We currently hold a prestigious Athena SWAN Silver award. We are ranked 1st in the UK for knowledge transfer partnerships, (Innovate UK) 9th in the UK for University facilities (Times Higher Education Student Experience Survey 2018) and 14th in the UK for research quality (Times and Sunday Times Good University Guide 2019).

Candidate Information 

Informal enquiries may be directed to Dr Philip Dunne via email to p.dunne@qub.ac.uk 

About the Centre 
Further Information for International Applicants 
Note to EAA applicants on Brexit